Schechter Joshua 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Lifecore (LFCR) Director Joshua Schechter Receives 25,907-Share RSU Award
What Happened
- Joshua Schechter, a director of Lifecore Biomedical, Inc. (LFCR), was granted 25,907 restricted stock units (RSUs) on June 4, 2026. The filing reports an award (code A); no purchase price or cash consideration is listed. Per the filing, each RSU converts into one share of Lifecore common stock on a 1-for-1 basis at settlement.
Key Details
- Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (appears filed the next business day).
- Award size: 25,907 RSUs; no per-share price reported (N/A).
- Conversion: RSUs convert into common stock on a 1-for-1 basis (Footnote F1).
- Vesting: RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting (provided that meeting is at least 50 weeks after June 4, 2026) (Footnote F2).
- Shares owned after the grant: not specified in the filing.
- Transaction type: Award/Grant (compensation), not a market purchase or sale.
Context
- RSU grants are a form of equity compensation that typically convert to shares at vesting and may be forfeited if vesting conditions aren’t met; they do not represent an immediate sale or purchase signal. This filing documents a compensation award to a director rather than an open-market trade.
Insider Transaction Report
Form 4
Schechter Joshua
Director
Transactions
- Award
Common Stock
[F1][F2]2026-06-04+25,907→ 133,080 total
Footnotes (2)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).
Signature
/s/ Courtney Schuler, Attorney-In-Fact for Joshua Schechter|2026-06-05